David J. Drachman served as the CEO of AtriCure, Inc., a medical device company, from its founding in 2000 until September 2012. He played a significant role in shaping the company's growth in the medical device industry. In 2010, he...
David J. Drachman served as the CEO of AtriCure, Inc., a medical device company, from its founding in 2000 until September 2012. He played a significant role in shaping the company's growth in the medical device industry. In 2010, he earned a total compensation of $620,468, which included a performance-based bonus for achieving operational goals. Drachman made some notable insider trades; for example, between September 2019 and January 2021, the value of his holdings fluctuated significantly, reaching a peak of $19.05 million in July 2021 before settling at about $10.22 million by January 2023. Interestingly, after resigning, he continued a unique agreement that allowed him to receive benefits until 2013. Drachman's tenure as CEO was marked by a commitment to aligning executive pay with the company's performance, showing a structured approach to leadership in a competitive market.